This included pregnancies with clinical laboratory evidence of recent unspecified maternal flavivirus infection, and those with negative maternal Zika virus IgM, where possible maternal exposure occurred >12 weeks before serum collection. The gene discussed is CD40LG; the disease is Flavivirus Infections.